Vanda Pharmaceuticals Inc. (VNDA): Price and Financial Metrics

VNDA POWR Grades

• VNDA scores best on the Value dimension, with a Value rank ahead of 99.7% of US stocks.
• The strongest trend for VNDA is in Growth, which has been heading down over the past 179 days.
• VNDA ranks lowest in Growth; there it ranks in the 6th percentile.

VNDA Stock Summary

• For VNDA, its debt to operating expenses ratio is greater than that reported by merely 9.8% of US equities we're observing.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 1.17 for Vanda Pharmaceuticals Inc; that's greater than it is for only 11.67% of US stocks.
• With a year-over-year growth in debt of -12.54%, Vanda Pharmaceuticals Inc's debt growth rate surpasses 26.93% of about US stocks.
• Stocks that are quantitatively similar to VNDA, based on their financial statements, market capitalization, and price volatility, are NATI, THRM, WB, CLPT, and MDRX.
• VNDA's SEC filings can be seen here. And to visit Vanda Pharmaceuticals Inc's official web site, go to www.vandapharma.com.

VNDA Valuation Summary

• In comparison to the median Healthcare stock, VNDA's price/earnings ratio is 21.37% lower, now standing at 28.7.
• VNDA's price/sales ratio has moved NA NA over the prior 187 months.
• Over the past 187 months, VNDA's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for VNDA.

VNDA Growth Metrics

Its 4 year net income to common stockholders growth rate is now at 377.72%.
• Its year over year price growth rate is now at 55.92%.
• The 2 year price growth rate now stands at -19.5%.

VNDA's revenue has moved up $147,645,000 over the prior 70 months.

The table below shows VNDA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	268.682	64.214	33.152
2021-09-30	268.316	56.909	34.264
2021-06-30	258.529	56.886	32.44
2021-03-31	252.837	61.875	31.501
2020-12-31	248.168	51.775	23.337
2020-09-30	241.445	42.264	19.363

VNDA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• VNDA has a Quality Grade of B, ranking ahead of 90.12% of graded US stocks.
• VNDA's asset turnover comes in at 0.483 -- ranking 88th of 682 Pharmaceutical Products stocks.
• NEOG, CLVS, and AMRN are the stocks whose asset turnover ratios are most correlated with VNDA.

The table below shows VNDA's key quality metrics over time.